Sérgio Augusto Antunes Ramos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sérgio Augusto Antunes Ramos has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- André Luiz Bittencourt de Amorim Farias
Faculdade Integrada Brasil Amazônia
2 shared publications - Beatriz Oliveira Amaro
Instituto Evandro Chagas
2 shared publications - Daniel de Souza Avelar
Universidade Federal do Pará, Brazil
2 shared publications - Fabiano Cordeiro Moreira
Oncology Research Center, Federal University of Pará, Belem, Brazil
2 shared publications - Geraldo Ishak
Universidade Federal do Pará, Brazil
2 shared publications - Julyana Lago Pinto da Silva
Escola Superior da Amazônia
2 shared publications
Latest Publications
- Open Access
- 6 March 2026
- Published by Wiley in Molecular Carcinogenesis
- Vol. 65 (6) , 665-676
Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population
Prostate cancer (PCa) is the second most frequently diagnosed malignancy among men and the sixth leading cause of cancer‐related mortality worldwide. Radical prostatectomy remains the standard treatment for localized disease; however, approximately one‐third of patients develop biochemical recurrence within 10 years. Although prostate‐specific antigen (PSA) is the primary biomarker used for diagnosis and monitoring, additional molecular markers such as PTEN loss and MYC amplification have been investigated to improve prognostic stratification. Liquid biopsy has emerged as a promising tool in oncology, yet the clinical significance of circulating tumor cells (CTCs) in early‐stage PCa remains uncertain. This prospective, single‐center study included 50 patients with localized prostate cancer from the Brazilian Amazon region who underwent radical prostatectomy in 2023. Peripheral blood samples were collected preoperatively and postoperatively for CTC enumeration and molecular characterization using Cytelligen SET‐iFISH and the CellSearch system. PTEN and MYC status were evaluated to further characterize the detected CTC population. CTCs were detected in all patients prior to surgery, with a significant reduction observed after radical prostatectomy ( p < 0.001); 88% of patients had no detectable CTCs postoperatively. PTEN loss was identified in 12% of patients, all of whom presented with ISUP grade ≥ 2 disease. MYC amplification was rare, observed in only one patient with Gleason score 7 and concomitant PTEN deletion. These findings suggest that perioperative CTC detection may provide clinically relevant prognostic information in localized PCa. PTEN loss appears to represent an early molecular alteration associated with adverse pathological features. Longer follow‐up is needed to determine the predictive value of these biomarkers for recurrence and long‐term outcomes.
- 6 March 2026
- Published by Wiley in Molecular Carcinogenesis
- Vol. 65 (6) , 665-676
Open AccessDynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population
Prostate cancer (PCa) is the second most frequently diagnosed malignancy among men and the sixth leading cause of cancer‐related mortality worldwide. Radical prostatectomy remains the standard treatment for localized disease; however, approximately one‐third of patients develop biochemical recurrence within 10 years. Although prostate‐specific antigen (PSA) is the primary biomarker used for diagnosis and monitoring, additional molecular markers such as PTEN loss and MYC amplification have been investigated to improve prognostic stratification. Liquid biopsy has emerged as a promising tool in oncology, yet the clinical significance of circulating tumor cells (CTCs) in early‐stage PCa remains uncertain. This prospective, single‐center study included 50 patients with localized prostate cancer from the Brazilian Amazon region who underwent radical prostatectomy in 2023. Peripheral blood samples were collected preoperatively and postoperatively for CTC enumeration and molecular characterization using Cytelligen SET‐iFISH and the CellSearch system. PTEN and MYC status were evaluated to further characterize the detected CTC population. CTCs were detected in all patients prior to surgery, with a significant reduction observed after radical prostatectomy ( p < 0.001); 88% of patients had no detectable CTCs postoperatively. PTEN loss was identified in 12% of patients, all of whom presented with ISUP grade ≥ 2 disease. MYC amplification was rare, observed in only one patient with Gleason score 7 and concomitant PTEN deletion. These findings suggest that perioperative CTC detection may provide clinically relevant prognostic information in localized PCa. PTEN loss appears to represent an early molecular alteration associated with adverse pathological features. Longer follow‐up is needed to determine the predictive value of these biomarkers for recurrence and long‐term outcomes.
- Open Access
FERROPTOSIS GENE SIGNATURES REVEAL DISTINCT REGULATORY LANDSCAPES IN GASTRIC ADENOCARCINOMA AND OTHER TISSUES
Background: Gastric adenocarcinoma (GAC) remains one of the most lethal malignancies worldwide, with late-stage diagnosis and limited therapeutic options. Ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, has emerged as a promising target for overcoming tumor resistance mechanisms. This study aimed to characterize the transcriptional landscape of ferroptosis-related genes in GAC, comparing tumor, peritumoral, metaplastic, and normal gastric tissues. Methods: RNA-Seq was performed on 385 biopsied samples from patients treated at the João de Barros Barreto University Hospital. Differential expression analysis was conducted using DESeq2, and genes related to ferroptosis were identified based on FerrDb V2 annotations. Visualization included volcano plots, DAPC clustering, heatmaps, and gene dominance scoring. Results: GAC samples showed a distinct ferroptotic expression signature, with simultaneous upregulation of key promoters (e.g., CDKN2A, NOX4, EGFR, IL6 ) and suppressors (e.g., HSPB1, SCD, NUPR1, GDF15 ). Notably, the tumor tissue exhibited a net dominance of ferroptosis-inhibitory genes, suggesting an adaptive response to oxidative stress. Adjacent tissues showed partial overlap with tumor profiles, while metaplastic tissue displayed a hybrid signature with selective suppression of ferroptosis. Normal mucosa exhibited dominant expression of promoters, contrasting with the tumor’s anti-ferroptotic phenotype. Conclusion: The transcriptional heterogeneity and regulatory imbalance of ferroptosis-related genes in GAC support its role as a potential therapeutic axis. These findings provide molecular insights for biomarker discovery and ferroptosis-targeted strategies in gastric cancer.
Open AccessFERROPTOSIS GENE SIGNATURES REVEAL DISTINCT REGULATORY LANDSCAPES IN GASTRIC ADENOCARCINOMA AND OTHER TISSUES
Background: Gastric adenocarcinoma (GAC) remains one of the most lethal malignancies worldwide, with late-stage diagnosis and limited therapeutic options. Ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, has emerged as a promising target for overcoming tumor resistance mechanisms. This study aimed to characterize the transcriptional landscape of ferroptosis-related genes in GAC, comparing tumor, peritumoral, metaplastic, and normal gastric tissues. Methods: RNA-Seq was performed on 385 biopsied samples from patients treated at the João de Barros Barreto University Hospital. Differential expression analysis was conducted using DESeq2, and genes related to ferroptosis were identified based on FerrDb V2 annotations. Visualization included volcano plots, DAPC clustering, heatmaps, and gene dominance scoring. Results: GAC samples showed a distinct ferroptotic expression signature, with simultaneous upregulation of key promoters (e.g., CDKN2A, NOX4, EGFR, IL6 ) and suppressors (e.g., HSPB1, SCD, NUPR1, GDF15 ). Notably, the tumor tissue exhibited a net dominance of ferroptosis-inhibitory genes, suggesting an adaptive response to oxidative stress. Adjacent tissues showed partial overlap with tumor profiles, while metaplastic tissue displayed a hybrid signature with selective suppression of ferroptosis. Normal mucosa exhibited dominant expression of promoters, contrasting with the tumor’s anti-ferroptotic phenotype. Conclusion: The transcriptional heterogeneity and regulatory imbalance of ferroptosis-related genes in GAC support its role as a potential therapeutic axis. These findings provide molecular insights for biomarker discovery and ferroptosis-targeted strategies in gastric cancer.
- Open Access
Characterization of Human Endogenous Retroviruses in Gastric Cancer with Helicobacter pylori : A Study from Northern Brazil
Human endogenous retroviruses (HERVs) are retroelements that have integrated their genetic material into the human genome, accumulating mutations over time and accounting for approximately 8% of the genome. Under abnormal deregulation conditions, these elements can be expressed and contribute to the development of diseases, such as gastric cancer. This malignancy may be associated with infections, including those caused by Helicobacter pylori . However, the scientific literature does not yet provide clear evidence regarding the relationship between HERVs and H. pylori in the context of gastric cancer. Thus, HERVs may represent potential biomarkers for this neoplasm, as well as possible therapeutic targets. This study aimed to characterize HERV expression in gastric cancer using next-generation sequencing (NGS). We analyzed 46 tumor tissue samples and 42 peritumoral tissue samples from patients diagnosed with gastric adenocarcinoma, collected at HUJBB and Ophir Loyola hospitals. Among the tumor samples, 38 tested positive for H. pylori infection. For library preparation, 1 μg of total RNA per sample was used, with integrity assessed via TapeStation (∼260 bp band). cDNA libraries were sequenced using the Illumina NextSeq 500 platform (paired-end), following the ID Output V2 kit protocol. Alignment was performed with STAR software, and HERVs were identified and quantified using Telescope. Differential expression analysis of HERVs was performed on transcript data using DESeq2. A total of 183 HERVs were found to be differentially expressed in tumor tissues compared to adjacent tissues. In tumor samples associated with H. pylori infection, 44 HERVs showed differential expression. Overall, tumor tissues exhibited higher HERV transcription compared to adjacent tissues.
Open AccessCharacterization of Human Endogenous Retroviruses in Gastric Cancer with Helicobacter pylori : A Study from Northern Brazil
Human endogenous retroviruses (HERVs) are retroelements that have integrated their genetic material into the human genome, accumulating mutations over time and accounting for approximately 8% of the genome. Under abnormal deregulation conditions, these elements can be expressed and contribute to the development of diseases, such as gastric cancer. This malignancy may be associated with infections, including those caused by Helicobacter pylori . However, the scientific literature does not yet provide clear evidence regarding the relationship between HERVs and H. pylori in the context of gastric cancer. Thus, HERVs may represent potential biomarkers for this neoplasm, as well as possible therapeutic targets. This study aimed to characterize HERV expression in gastric cancer using next-generation sequencing (NGS). We analyzed 46 tumor tissue samples and 42 peritumoral tissue samples from patients diagnosed with gastric adenocarcinoma, collected at HUJBB and Ophir Loyola hospitals. Among the tumor samples, 38 tested positive for H. pylori infection. For library preparation, 1 μg of total RNA per sample was used, with integrity assessed via TapeStation (∼260 bp band). cDNA libraries were sequenced using the Illumina NextSeq 500 platform (paired-end), following the ID Output V2 kit protocol. Alignment was performed with STAR software, and HERVs were identified and quantified using Telescope. Differential expression analysis of HERVs was performed on transcript data using DESeq2. A total of 183 HERVs were found to be differentially expressed in tumor tissues compared to adjacent tissues. In tumor samples associated with H. pylori infection, 44 HERVs showed differential expression. Overall, tumor tissues exhibited higher HERV transcription compared to adjacent tissues.
- Open Access
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
A relação entre a obesidade infantil e a infecção pelo adenovírus 36: uma revisão narrativa
A obesidade infantil consiste em sério problema de saúde pública mundial, por se tratar de uma doença crônica não transmissível que atinge uma grande parte da população independente do gênero, classe social e idade, uma doença de causas multifatoriais que é caracterizada principalmente pelo acúmulo generalizado de gordura. Porém, apesar dos fatores já investigados como genéticos, culturais, religiosos e comportamentais, uma variável pouco citada se trata da influência de agentes microbiológicos nesse processo tem sido investigada na últimas décadas visando compreender se há relação e nesse sentido foram encontrados alguns agentes virais que estavam relacionados a modelos animais e posteriormente aos humanos dentre esses o Adenovírus 36 tem sido apontado como um dos principais a corroborar na gênese de distúrbios nutricionais e metabólicos a obesidade infantil. Visto isso, este estudo se propôs a realizar uma revisão narrativa da literatura sobre a relação entre a obesidade infantil e o adenovírus 36. Na busca dos artigos foi possível se chegar a um total de 161 resultados, porém após a triagem 10 foram selecionados para síntese da revisão e além disso outros autores foram implementados para reforçar as ideias apresentadas. Conclui-se que a obesidade infantil permanece sendo uma patologia de extrema relevância para a saúde e que além dos fatores já conhecidos há indícios da relação entre o adv 36 e a obesidade em crianças em diferentes populações de estudos.
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Open AccessA relação entre a obesidade infantil e a infecção pelo adenovírus 36: uma revisão narrativa
A obesidade infantil consiste em sério problema de saúde pública mundial, por se tratar de uma doença crônica não transmissível que atinge uma grande parte da população independente do gênero, classe social e idade, uma doença de causas multifatoriais que é caracterizada principalmente pelo acúmulo generalizado de gordura. Porém, apesar dos fatores já investigados como genéticos, culturais, religiosos e comportamentais, uma variável pouco citada se trata da influência de agentes microbiológicos nesse processo tem sido investigada na últimas décadas visando compreender se há relação e nesse sentido foram encontrados alguns agentes virais que estavam relacionados a modelos animais e posteriormente aos humanos dentre esses o Adenovírus 36 tem sido apontado como um dos principais a corroborar na gênese de distúrbios nutricionais e metabólicos a obesidade infantil. Visto isso, este estudo se propôs a realizar uma revisão narrativa da literatura sobre a relação entre a obesidade infantil e o adenovírus 36. Na busca dos artigos foi possível se chegar a um total de 161 resultados, porém após a triagem 10 foram selecionados para síntese da revisão e além disso outros autores foram implementados para reforçar as ideias apresentadas. Conclui-se que a obesidade infantil permanece sendo uma patologia de extrema relevância para a saúde e que além dos fatores já conhecidos há indícios da relação entre o adv 36 e a obesidade em crianças em diferentes populações de estudos.
- Open Access
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Panorama da imunização quadrivalente em adolescentes mulheres contra o Papillomavirus Humano ao longo de quatro anos: uma análise entre regiões do Brasil
Introdução: O Papillomavirus Humano é uma das maiores etiologias de infecções sexualmente transmissíveis e doenças oncogênicas no mundo, em que possui sorotipos virais de baixo e alto riscos oncogênicos (HPV-6, -11, -16 e -18). Muitas vacinas foram desenvolvidas para conter a dispersão da infecção, dentre elas, a quadrivalente, que confere proteção a estes sorotipos virais. Contudo, a cobertura vacinal do imunizante no Brasil é insatisfatória em diferentes regiões do país, especialmente no grupo adolescente feminino. Objetivo: Descrever o panorama da vacinação quadrivalente feminina entre as regiões brasileiras ao longo de quatro anos. Metodologia: Os dados foram obtidos do banco de dados públicos TABNET – Imunizações, considerando: todas as regiões, período de 2016 a 2019, imunizante quadrivalente HPV-feminino-1ª/2ª-doses e idade de 10 a 15 anos. Os dados foram organizados em planilha Excel e analisados em software RStudio, no qual toda a linguagem gráfica foi produzida. Resultados: Observou-se que o número de aplicações se elevou no primeiro biênio da análise, mas reduziu expressivamente no segundo, além de que o cenário vacinal da primeira dose não acompanha o da segunda, refletindo diretamente na cobertura vacinal do imunizante no país. Conclusão: a pesquisa demonstrou graficamente o panorama vacinal quadrivalente feminino, evidenciando que o mesmo se apresenta insatisfatório, uma vez que estudos recentes também salientam as lacunas existentes na cobertura vacinal, além de citarem a heterogeneidade regional no que tange a realidade vacinal de cada localidade do Brasil.
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Open AccessPanorama da imunização quadrivalente em adolescentes mulheres contra o Papillomavirus Humano ao longo de quatro anos: uma análise entre regiões do Brasil
Introdução: O Papillomavirus Humano é uma das maiores etiologias de infecções sexualmente transmissíveis e doenças oncogênicas no mundo, em que possui sorotipos virais de baixo e alto riscos oncogênicos (HPV-6, -11, -16 e -18). Muitas vacinas foram desenvolvidas para conter a dispersão da infecção, dentre elas, a quadrivalente, que confere proteção a estes sorotipos virais. Contudo, a cobertura vacinal do imunizante no Brasil é insatisfatória em diferentes regiões do país, especialmente no grupo adolescente feminino. Objetivo: Descrever o panorama da vacinação quadrivalente feminina entre as regiões brasileiras ao longo de quatro anos. Metodologia: Os dados foram obtidos do banco de dados públicos TABNET – Imunizações, considerando: todas as regiões, período de 2016 a 2019, imunizante quadrivalente HPV-feminino-1ª/2ª-doses e idade de 10 a 15 anos. Os dados foram organizados em planilha Excel e analisados em software RStudio, no qual toda a linguagem gráfica foi produzida. Resultados: Observou-se que o número de aplicações se elevou no primeiro biênio da análise, mas reduziu expressivamente no segundo, além de que o cenário vacinal da primeira dose não acompanha o da segunda, refletindo diretamente na cobertura vacinal do imunizante no país. Conclusão: a pesquisa demonstrou graficamente o panorama vacinal quadrivalente feminino, evidenciando que o mesmo se apresenta insatisfatório, uma vez que estudos recentes também salientam as lacunas existentes na cobertura vacinal, além de citarem a heterogeneidade regional no que tange a realidade vacinal de cada localidade do Brasil.